最新の財務諸表(Form-10K)によると、Outset Medical Incの総資産は$0で、純損失は$0です。
OMの主要な財務比率は何ですか?
Outset Medical Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Outset Medical Incの収益はセグメントまたは地域別にどのように分けられていますか?
Outset Medical Inc の最大収益セグメントは Consumables で、最新の利益発表における収益は 54,075,000 です。地域別に見ると、United States が Outset Medical Inc の主要市場であり、収益は 119,476,000 です。
Outset Medical Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Outset Medical Incの純損失は$0です。
Outset Medical Incに負債はありますか?
いいえ、Outset Medical Incの負債は0です。
Outset Medical Incの発行済株式数は何株ですか?
Outset Medical Incの総発行済株式数は0株です。
主要データ
前終値
$3.86
始値
$3.85
当日レンジ
$3.84 - $4.41
52週レンジ
$3 - $21.98
取引高
247.2K
平均取引高
555.9K
配当利回り
--
1株当たり利益(TTM)
-6.78
時価総額
$78.1M
OMとは何ですか?
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 310 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.